BHVN - Biohaven Ltd
Close
39.4
-0.410 -1.041%
Share volume: 853,091
Last Updated: Fri 30 Aug 2024 10:00:02 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$39.81
-0.41
-1.03%
View ratios
Fiscal Date | 2022-03-31 | 2022-06-30 | |
---|---|---|---|
Fiscal Quarter | Q1 2022 | Q2 2022 | |
Report Date | 2022-05-10 | 2022-08-05 | |
Cash flow financing | 267.991 M | 141.926 M | |
Other financing cash flows | 0.000 | 0.000 | |
Cash flow | -23.644 M | -134.036 M | |
Net income | -209.072 M | -441.387 M | |
Depreciation | 4.402 M | 5.381 M | |
Changes in inventories | 91.281 M | 106.561 M | |
Changes in receivables | 328.342 M | 352.449 M | |
Investing Cashflow | -244.270 M | 56.969 M | |
Net Borrowings | 108.138 M | 292.365 M | |
Investing Activity Other | 0.000 | 0.000 | |
Dividends Paid | 0.000 | 0.000 | |
Exchange Rate Effect | 0.000 | 0.000 | |
Capital Expenditures | -512.000 K | -21.881 M | |
Cash Change | 602.475 M | 553.486 M |